- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,130GBP
Pentazocine is an analgesic drug used to treat moderate to severe pain. It is a synthetic opioid agonist-antagonist, meaning it has both opioid agonist and antagonist properties. It is available in both oral and injectable forms, and is often used in combination with other analgesics. Pentazocine is a Schedule IV controlled substance in the United States, meaning it has a low potential for abuse and dependence.
Pentazocine is used to treat a variety of pain conditions, including postoperative pain, cancer pain, and chronic pain. It is also used to treat opioid addiction and withdrawal symptoms. Pentazocine is generally well-tolerated, but can cause side effects such as nausea, vomiting, dizziness, and drowsiness.
Some companies in the Pentazocine market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more